Literature DB >> 18315477

Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell carcinoma.

Steve K Williams1, Karin J Denton, Andrea Minervini, Jon Oxley, Jay Khastigir, Anthony G Timoney, Francis X Keeley.   

Abstract

PURPOSE: To determine the accuracy of radiographic studies, ureteroscopy, biopsy, and cytology in predicting the histopathology of upper-tract transitional cell carcinoma (TCC).
MATERIALS AND METHODS: From 1998 to 2006, 46 upper-tract lesions were diagnosed ureteroscopically and underwent nephroureterectomy, and 30 of them were subjected to direct ureteroscopic inspection and biopsy. Fresh samples were delivered to the cytopathology laboratory and histology samples were prepared whenever visible tissue was present. Radiological, ureteroscopic, cytology, and biopsy data were compared to the actual grades and stages of these 30 surgical specimens.
RESULTS: Retrograde ureteropyelography was suggestive of malignancy in 29 of 30 cases, but did not predict the grade or stage accurately. Cytology was positive for malignancy in 21 of 30 cases (70%). Grading of ureteroscopic specimens was possible in all cases. At nephroureterectomy two cases were found to have no tumor (T(0)). Of the remaining 28 cases, the biopsy grade proved to be identical in 21 (75%). Grade 1 or 2 ureteroscopic specimens had a low-stage (T(0), T(a), or T(1)) tumor in 17 of 25 (68%); in contrast, 3 of 5 (60%) high-grade specimens had invasive tumor (T(2) or T(3)). For patients with grade 2 ureteroscopic specimens, combining exfoliated cell cytology and biopsy grade improved the accuracy in predicting high-stage and high-grade disease.
CONCLUSIONS: This study confirms previous findings that ureteroscopic inspection and biopsy provides accurate information regarding the grade and stage of upper-tract TCC. Combining exfoliated cell cytology improves the predictive power of biopsy grade 2 disease for high-risk specimen grade and stage. Our data suggest that ureteroscopic findings may predict muscle invasion.

Entities:  

Mesh:

Year:  2008        PMID: 18315477     DOI: 10.1089/end.2007.9853

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  27 in total

1.  Upper urinary tract biopsy: an old device for a new approach.

Authors:  G Carrafiello; F Fontana; M Mangini; A M Ierardi; E Cotta; F Piacentino; M De Chiara; C Floridi; A Di Massa; A M Marconi; C Fugazzola
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

2.  Standardized ex vivo comparison of different upper urinary tract biopsy devices: impact on ureterorenoscopes and tissue quality.

Authors:  M Ritter; C Bolenz; T Bach; P Ströbel; A Häcker
Journal:  World J Urol       Date:  2012-03-27       Impact factor: 4.226

3.  Superiority of the EF-120-00-3F biopsy forceps in the histopathological evaluation of upper urinary tract specimens.

Authors:  Mario W Kramer; Mahmoud Abbas; Mohammad Kabbani; Florian Imkamp; Udo Nagele; Thorsten Bach; Stephan Jutzi; Christoph von Klot; Jan Becker; Axel S Merseburger; Markus A Kuczyk; Hans H Kreipe; Thomas R Herrmann
Journal:  World J Urol       Date:  2013-12-17       Impact factor: 4.226

4.  Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?

Authors:  Mesut Remzi; Shahrokh Shariat; Wilhelm Huebner; Harun Fajkovic; Christian Seitz
Journal:  Ther Adv Urol       Date:  2011-04

5.  Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.

Authors:  Sima Porten; Arlene O Siefker-Radtke; Lianchun Xiao; Vitaly Margulis; Ashish M Kamat; Christopher G Wood; Eric Jonasch; Colin P N Dinney; Surena F Matin
Journal:  Cancer       Date:  2014-03-13       Impact factor: 6.860

6.  Diagnostic role of urine cytology and ureteroscopic biopsies in detection of high grade upper tract urothelial carcinoma.

Authors:  Yani Zhao; Fang-Ming Deng; Jonathan Melamed; William C Huang; Hongying Huang; Qinghu Ren
Journal:  Am J Clin Exp Urol       Date:  2021-06-15

Review 7.  Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review.

Authors:  Jan Cordier; Guru Sonpavde; Christian G Stief; Derya Tilki
Journal:  World J Urol       Date:  2012-09-29       Impact factor: 4.226

8.  Urinary cytology with acridine orange fluorescence is highly valuable for predicting high-grade upper urinary tract urothelial carcinoma.

Authors:  Jing Li; Zhihong Zhang; Jin Wang; Changwen Zhang; Haibo Li; Yong Xu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 9.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).

Authors:  Francesco Soria; Shahrokh F Shariat; Seth P Lerner; Hans-Martin Fritsche; Michael Rink; Wassim Kassouf; Philippe E Spiess; Yair Lotan; Dingwei Ye; Mario I Fernández; Eiji Kikuchi; Daher C Chade; Marko Babjuk; Arthur P Grollman; George N Thalmann
Journal:  World J Urol       Date:  2016-09-07       Impact factor: 4.226

10.  Endoscopic management of upper tract urothelial carcinoma.

Authors:  K Moore; J Khastgir; M Ghei
Journal:  Adv Urol       Date:  2009-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.